Lantern Pharma Inc (LTRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 5,409 | 5,732 | 4,877 | 3,524 | 5,190 |
| Operating Income | -5,409 | -5,732 | -4,877 | -3,524 | -5,190 |
| Other Income | 449 | 291 | 692 | 362 | 444 |
| Pre-tax Income | -4,960 | -5,441 | -4,186 | -3,162 | -4,746 |
| Net Income Continuous | -4,960 | -5,441 | -4,186 | -3,162 | -4,746 |
| Net Income | $-4,960 | $-5,441 | $-4,186 | $-3,162 | $-4,746 |
| EPS Basic Total Ops | -0.46 | -0.51 | -0.38 | -0.29 | -0.44 |
| EPS Basic Continuous Ops | -0.46 | -0.51 | -0.39 | -0.29 | -0.44 |
| EPS Diluted Total Ops | -0.46 | -0.51 | -0.38 | -0.29 | -0.44 |
| EPS Diluted Continuous Ops | -0.46 | -0.51 | -0.39 | -0.29 | -0.44 |
| EPS Diluted Before Non-Recurring Items | -0.46 | -0.51 | -0.39 | -0.29 | N/A |
| EBITDA(a) | $-5,463 | $-5,762 | $-4,931 | $-3,549 | $-5,213 |